Pharma exports from region up by over 60%

INDORE: Pharmaceutical exports from the region have registered a growth of over 60 per cent this year as against the previous year led by higher orders and up-gradation in firms.

According to data from Development Commissioner Special Economic Zone (SEZ), exports from pharmaceutical firms in fiscal year 2018/19 stood at Rs 3,771.54 crore, up 67.62 per cent as against Rs 2,249.93 crore in the past year.

An HR executive from a leading pharmaceutical company located in the Special Economic Zone (SEZ) said, “This year was extraordinary for us because the number of orders were high from our customers after we upgraded and passed certain international standards mandatory for exports.”

Pithampur has over 20 pharmaceutical companies and more new companies are expected to set up facilities in the region in coming years as the region has become the hub for pharmaceutical companies.

Another executive from a Pithampur based drug manufacturing unit said, “In comparison to other states, the cost of operations are economical here as companies are getting the SEZ benefits. Electricity is cheap, subsidies are there in addition to other facilities that makes the companies competitive.”

Industrialists said opportunities are huge for pharmaceutical companies in the region as the cost of operations and labour are economical. They expect exports to grow further in the next year.

Industrialists said, the contribution of small-scale drug manufacturers are negligible in exports and to promote them some additional subsidies to help them bear the up-gradation costs should be provided.

Indore has over 120 small scale medicines manufacturing units engaged in production of sanitizers, ointments, syrups and injectable with over 10 units engaged in exports contributing about Rs 500 crore annual exports.

Alok Dave, president, Association of Industries Madhya Pradesh (AIMP) said, “Subsidies and financial assistance will help in increasing exports from small-scale drug manufacturers. The government should also develop a cluster to curtail the cost of operations of small manufacturers.”

  • Related Posts

    ‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

    On Thursday, Congress workers held protests against the “degrading medical conditions of Rajasthan” and attempted to enter the hospital premises. Rajasthan Health Minister Gajendra Singh Khinvsar’s remarks about women diagnosed…

    Price cap on 2 key cancer drugs increased by 50%

    NEW DELHI: Amid concerns over shortages of two critical cancer medicines, National Pharmaceutical Pricing Authority has approved a 50% hike in ceiling prices of Carboplatin and Cisplatin injections, citing escalating…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    ‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

    ‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

    Price cap on 2 key cancer drugs increased by 50%

    Price cap on 2 key cancer drugs increased by 50%

    Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

    Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

    IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

    IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

    Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

    Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

    No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case

    No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case